Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on July 27, 2026

Jul. 27, 2026

Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 27, 2026

FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner

Indeterminate GlobeNewswire

Jul. 27, 2026

Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs

Indeterminate GlobeNewswire

Jul. 27, 2026

Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure

Indeterminate GlobeNewswire

Jul. 27, 2026

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Jul. 27, 2026

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

Indeterminate GlobeNewswire

Jul. 27, 2026

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Picard Medical Receives NYSE American Acceptance of Compliance Plan

Indeterminate GlobeNewswire

Jul. 27, 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

Jul. 27, 2026

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

Indeterminate GlobeNewswire

Jul. 27, 2026

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

Indeterminate GlobeNewswire

Jul. 27, 2026

Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.

Indeterminate GlobeNewswire

Jul. 27, 2026

Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

CorVel Corporation to Host Live Earnings Release Webcast

Indeterminate GlobeNewswire

Jul. 27, 2026

The Ensign Group Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 27, 2026

Legend Biotech Announces CEO Transition

Indeterminate GlobeNewswire

Jul. 27, 2026

Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

Indeterminate GlobeNewswire